Viking Therapeutics, Inc.
Industry: Life Sciences ・ $VKTX on Nasdaq
Insider Sale
+$2,099,500
-3.62%
Shares
Shares Volume: 85,000 Shares
Average Share Price: $24.7
INSIDER
Lian Brian
President & CEO (Director)
reported on Jan 31 2024
traded on Jan 31 2024
TRADE ACTIVITY 1Y
current insider trade in blue
INSIDER ACTIVITY
NEW SHARES OWNERSHIP AMOUNT | 2,264,882 |
PURCHASES/SALES 1Y | 0 / 7 |
P/S VALUE RATIO | N/A |
AVERAGE SALE VALUE | $1,938,777.29 |
INSIDER PREVIOUS TRADES |
COMPANY OVERALL ACTIVITY
INSIDERS IN PAST 2 WEEKS with at least one purchase / sale | 0 / 2 |
PURCHASES/SALES 1Y | 0 / 18 |
P/S VALUE RATIO | N/A |
AVERAGE SALE VALUE | $1,409,121.7 |
COMPANY PREVIOUS TRADES |